Builds long, accurate synthetic DNA in days using its cell-free, microfluidics-based ENFINIA DNA platform.
Pioneers enzymatic DNA synthesis on the benchtop with SYNTAX, the first commercial enzymatic DNA printer, letting labs make oligos on demand.
Including Funding rounds + valuations, Founders + executives, Products + tech stack, Headcount + HQ, Status timeline, and Roster connections.
Already subscribed? Sign in →